Adalimumab or infliximab as monotherapy, or in combination with an immunomodulator, in the treatment of Crohn's disease.
about
Treatment Persistence for Infliximab Versus Adalimumab in Crohn's Disease: A 14-Year Single-Center Experience.Thiopurines and Methotrexate Use in IBD Patients in a Biologic Era.Systematic Review and Meta-analysis: Adalimumab Monotherapy Versus Combination Therapy with Immunomodulators for Induction and Maintenance of Remission and Response in Patients with Crohn's Disease.Comparison of infliximab with adalimumab in 827 biologic-naïve patients with Crohn's disease: a population-based Danish cohort study.Significance of measurement of serum trough level and anti-drug antibody of adalimumab as personalised pharmacokinetics in patients with Crohn's disease: a subanalysis of the DIAMOND trial.Efficacy and safety of golimumab in Crohn's disease: a French national retrospective study.The benefit of combination therapy depends on disease phenotype and duration in Crohn's disease.Editorial: adalimumab or infliximab as monotherapy, or in combination with an immunomodulator, in the treatment of Crohn's disease.Clinical activity is an independent risk factor of ischemic heart and cerebrovascular arterial disease in patients with inflammatory bowel disease
P2860
Q38883385-811A6E0A-E1ED-4451-A107-9D287BD0BA69Q39119181-5ACDF298-650B-4122-A906-2CC9CC9C2190Q39442118-63DCE87C-AEC5-4F44-9F6D-8DB029EF70B0Q46070749-2FE37786-4E3D-418C-B496-3FB71857155BQ47138621-01319898-0C6A-41C5-ACB5-0A2F78F65FB0Q48191965-9E795967-4CE0-4D8E-A841-71300CD922F5Q48194119-2CB1A6B3-9F00-4888-A1A4-4B846A9B66B1Q51290578-22509C27-2D12-4CE6-8835-D54DD619CE12Q58782501-3B4BFD31-94E5-45B5-BB46-5CF090401156
P2860
Adalimumab or infliximab as monotherapy, or in combination with an immunomodulator, in the treatment of Crohn's disease.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Adalimumab or infliximab as mo ...... treatment of Crohn's disease.
@en
Adalimumab or infliximab as mo ...... treatment of Crohn's disease.
@nl
type
label
Adalimumab or infliximab as mo ...... treatment of Crohn's disease.
@en
Adalimumab or infliximab as mo ...... treatment of Crohn's disease.
@nl
prefLabel
Adalimumab or infliximab as mo ...... treatment of Crohn's disease.
@en
Adalimumab or infliximab as mo ...... treatment of Crohn's disease.
@nl
P2093
P2860
P356
P1476
Adalimumab or infliximab as mo ...... treatment of Crohn's disease.
@en
P2093
A Bourrier
A Wisniewski
I Nion-Larmurier
L Beaugerie
P2860
P304
P356
10.1111/APT.13808
P407
P577
2016-09-26T00:00:00Z